Keywords: CD; Crohn's disease; CDAI; Crohn's Disease Activity Index; FDA; Food and Drug Administration; IBD; inflammatory bowel disease; PRO; patient-reported outcomes; PROMIS; Patient-Reported Outcomes Measurement Information System; UC; ulcerative colitis;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Rheumatoid arthritis; Interstitial lung disease; ACPA titer; CDAI; MHAQ;
Keywords: Crohn's disease; Infliximab; Perianal fistula; Biologics; TNF-α; Tumor necrosis factor α; CDAI; Crohn's disease activity index; PDAI; Perianal Crohn's disease activity index; BMI; Body mass index; 5-ASA; Aminosalicylates; IQR; Interquartile range;
Keywords: CD; Crohn's disease; CDAI; CD activity index; CDEIS; CD endoscopic index of severity; CLE; confocal laser endomicroscopy; CRP; C-reactive protein; IBD; irritable bowel disease; IQR; interquartile range; RR; relative risk; UC; ulcerative colitis;
Keywords: Inflammatory Bowel Diseases; Formalin-Fixed; Paraffin-Embedded; Next-Generation Sequencing; RNA-Seq; CD; Crohn disease; CDAI; Clinical Disease Activity Index; FFPE; formalin-fixed, paraffin-embedded; H&E; hematoxylin and eosin; I-Wk0; induction baseline;
Keywords: UNITI Trials; Inflammatory Bowel Disease Treatment; IBD; Anti-IL12/23; 6-MP; 6-mercaptopurine; AUC; area under the curve; AZA; azathioprine; CD; Crohn's disease; CDAI; Crohn's Disease Activity Index; CRP; Creactive protein; ECLIA; electrochemilumines
Keywords: ACPA; anti-citrullinated protein antibodies; ACR; American College of Rheumatology; BFU-E; burst-forming unit; CBC; complete blood count; CDAI; clinical disease activity index; CFU-GEMM; common myeloid progenitor; CFU-GM; granulocyte/macrophage colony-for
Keywords: Inflammatory Bowel Diseases; Hematopoietic Stem Cell Transplantation; Mesenchymal Stem Cell Transplantation; AD; adipocyte-derived; BM; bone marrow; CD; Crohn's disease; CDAI; Crohn's Disease Activity Index; HSCT; hematopoietic stem cell transplantati
Keywords: CE; Capsule Endoscopy; CESI; Capsule Endoscopy Scoring Index; CD; Crohn's disease; CDAI; Crohn's Disease Activity Index; CRP; C-reactive protein;
Keywords: Diet; Amino Acid; Kynurenine; Inflammation; Anti-Inflammatory; AHR; aryl hydrocarbon receptor; AUC; area under the curve; CAI; Clinical Activity Index for Ulcerative Colitis; CARD9; caspase recruitment domain family member 9; CD; Crohn's disease; CDAI;
Keywords: AAPH; 2,2'-Azobis(2-amidinopropane) dihydrochloride; ALS; Amyotrophic lateral sclerosis; AMI; Acute myocardial infarction; BCD; Basal conjugated dienes; BMI; Body mass index; CAD; Coronary artery disease; CD; Conjugated dienes; CDAI; Crohn's disease activ
Keywords: CDAI; DAS28; Leflunomide; Methotrexate; Rheumatoid arthritis;
Keywords: Cp; calprotectin; IBD; inflammatory bowel disease; FIT; fecal immunochemical test; HEPES; 2-[4-(2-hydroxyethyl)-1-piperazinyl]ethanesulfonic acid; BSA; bovine serum albumin; CD; Crohn's disease; UC; ulcerative colitis; CDAI; Crohn's disease activity index
Keywords: Crohn's disease; POSSUM; CDAI; Nutritional prognostic index; Postoperative morbidity; Postoperative mortality;
Keywords: EEsAI; Remission; Endoscopic Grading; Disease Monitoring; AUC; area under the curve; CDAI; Crohn's Disease Activity Index; EEsAI; Eosinophilic Esophagitis Activity Index; EoE; eosinophilic esophagitis; EGD; esophagogastroduodenoscopy; hpf; high-power fi
Keywords: Patient-Reported Outcomes; Telemedicine; Severity; Management; AUC; area under the curve; CD; Crohn's disease; CDAI; Crohn's disease activity index; DA-VAS; disease activity visual analogue scale; HBI; Harvey Bradshaw index; Hgb; hemoglobin; IBD; infl
Keywords: Disease Severity; Disease Course; Inflammatory Bowel Disease; CD; Crohn's disease; CDAI; Crohn's Disease Activity Index; CRP; C-reactive protein; ECCO; European Crohn's and Colitis Organisation; EIM; extraintestinal manifestation; ESR; erythrocyte s
Keywords: CDAI; RAPID-3; DAS-28; SDAI; Joint count;
Keywords: Rheumatoid arthritis; Remission; Ultrasound; ACR; American College of Rheumatology; CDAI; Clinical Disease Activity Index; DAS; Disease Activity Score; DP; Power Doppler Ultrasound; PGA; Patient Global Assessment; GPA; Global Physician Assessment; EULAR;
Keywords: CD; Crohn disease; CDAI; Crohn disease activity index; MRI; magnetic resonance imaging; MSC; mesenchymal stem cell; PDAI; perianal disease activity index;
Keywords: AE; adverse event; CDAI; Crohn's Disease Activity Index; EIR; extended intestinal release; IBS; irritable bowel syndrome; IBS-D; diarrhea-predominant irritable bowel syndrome;
Keywords: Inflammatory Bowel Disease; Diagnostic; Imaging; Monitoring; CD; Crohn's disease; CDAI; Crohn's Disease Activity Index; CDEIS; Crohn's Disease Endoscopic Index of Severity; CI; confidence interval; GELS; Global Evaluation of Lesion; ICC; intraclass
Keywords: Inflammatory Bowel Disease; Fecal Biomarkers; Prognostic Factor; Prognosis; AUROC; area under the receiver operator characteristic; CD; Crohn's disease; CDAI; Crohn's Disease Activity Index; CDEIS; Crohn's Disease Endoscopic Index of Severity; CRP;
Keywords: Comparative Effectiveness; Network Meta-Analysis; Crohn's Disease; Postoperative Prophylaxis; CD; Crohn's disease; CDAI; Crohn's Disease Activity Index; CI; confidence interval; CrI; credible interval; ITT; intention-to-treat; RCT; randomized contro
Keywords: Network Meta-analysis; IBD; Anti-TNF Therapy; Immunosuppressive Agents; CDAI; Crohn's Disease Activity Index; CrI; credible interval; OR; odds ratio; TNF; tumor necrosis factor; WDAE; withdrawals due to adverse events;
Keywords: IBD; Immune Suppression; Clinical Trial; Inflammatory Bowel Disease; ACCENT; A Crohn's Disease Clinical Trial Evaluating Infliximab in a New Long-term Treatment Regimen; CDAI; Crohn's Disease Activity Index; CI; confidence interval; IM; immunomodulator;
Keywords: Cell Therapy; Perianal Fistulas; Treatment; Inflammatory Bowel Disease; CD; Crohn's disease; CDAI; Crohn's Disease Activity Index; IL; interleukin; LUMC; Leiden University Medical Center; MRI; magnetic resonance imaging; MSC; mesenchymal stromal cell;
Keywords: Gut microbiota; Inflammatory bowel disease; Metagenomics; Probiotics; Fecal microbiota transplantation; Therapy; ATG16L1; autophagy-related protein 16L1; Bacteroides ovatus; B. ovatus; Bifidobacterium breve; B. breve; Bifidobacterium longum; B. longum; CD
Keywords: UC; Ulcerative colitis; CD; Crohn's disease; IBD; Inflammatory bowel disease; SIBDCS; Swiss Inflammatory Bowel Disease Cohort Study; ACD; Anemia of chronic disease; CRP; C-reactive protein; CDAI; Crohn's disease activity index; MTWAI; Modified Truelove an
Keywords: SE; sequential capsule endoscopy; CD; Crohn's disease; SB; small bowel; CDAI; Crohn's Disease Activity Index; IBDQ; Inflammatory Bowel Disease Questionnaire; SICUS; small intestinal contrast ultrasonography; Capsule endoscopy; Crohn's disease; Sequential
Keywords: COMMIT; Inflammatory Bowel Disease; IBD; Randomized Controlled Trial; CBC; complete blood count; CD; Crohn's disease; CDAI; Crohn's Disease Activity Index; CI; confidence interval; CRP; C-reactive protein; SF-36; Short-Form 36;
Keywords: AZA; azathioprine; CDAI; Crohn's disease activity index; 95% CI; 95% confidence interval; CRP; C-reactive protein; CD; Crohn's disease; HGPRT; hypoxanthine-guanine phosphoribosyl transferase; HPLC; high performance liquid chromatography; IBD; inflammatory
Keywords: CD; Crohn's disease; CDAI; Crohn's disease activity index; IBD-DI; Inflammatory bowel disease disability index; IBDQ; Inflammatory Bowel Disease Questionnaire; ICF; International Classification of Functioning, Disability and Health; pMayo; partial Mayo sc
Keywords: 6-MP; 6-mercaptopurine; AE; adverse event; CDAI; Crohn's Disease Activity Index; CI; confidence interval; CRP; C-reactive protein; ECCO; European Crohn's and Colitis Organisation; GIQLI; Gastrointestinal Quality of Life Index; ITT; intention-to-treat; LOC
Keywords: ASCA; Anti-Saccharomyces cerevisiae antibodies; AUC; Area under the ROC curve; CAI; Clinical activity index; CD; Crohn's disease; CDAI; Crohn's disease activity index; GC/MS; Gas chromatography/mass spectrometry; GSEA; Gene set enrichment analysis; HV; He
Keywords: ADA; adalimumab; CD; Crohn disease; CDAI; Crohn's Disease Activity Index; CrI; credible interval; CZP; certolizumab pegol; HR; hazard ratio; IBD; inflammatory bowel disease; IFX; infliximab; IL-12/23; interleukin 12/23; NAT; natalizumab; OR; odds ratio;
Keywords: SICUS; Crohn's Disease; Transmural Bowel Damage; Anti-TNFα; Drug Monitoring; CD; Crohn's disease; CDAI; Crohn's disease activity index; CRP; C-reactive protein; CT; computed tomography; LN; lumen narrowing; MH; mucosal healing; MR; magnetic resonance; SI
Keywords: IBD; Diagnosis; Ulcer; Intestinal Damage; AMLs; all mucosal lesions; CDAI; Crohn's disease Activity Index; CI; confidence interval; CRP; C-reactive protein; CT; computed tomography; DBE; double-balloon endoscopy; ICS; ileocolonoscopy; MR; magnetic resonan
Keywords: IBD; Inflammatory Bowel Disease; CD; Crohn's disease; hsCRP; high sensitivity CRP; CDAI; Crohn's Disease Activity Index; CDEIS; Crohn's Disease Endoscopic Index of Severity; Serum calprotectin; Crohn's disease; Biomarker; Relapse prediction; Infliximab;
Keywords: CD; Crohn's Disease; CDAI; Crohn's Disease Activity Index; CRP; C-reactive protein; ECCO; European Crohn's and Colitis Organisation; NPV; negative predictive value; PPV; positive predictive value; TNF-α; tumor necrosis factor alpha.; Crohn's; Clinical co
Keywords: IBD Ahead; Annual excHangE on the ADvances in Inflammatory Bowel Disease; CD; Crohn's disease; CDAI; Crohn's Disease Activity Index; CDEIS; Crohn's Disease Endoscopic Index of Severity; CRP; C-reactive protein; CT; computed tomography; GI; gastrointestina
Keywords: AZTEC Study; Inflammatory Bowel Diseases; Treatment; Corticosteroids; CD; Crohn's disease; CDAI; Crohn's Disease Activity Index; CI; confidence interval; CRP; C-reactive protein; IBDQ; Inflammatory Bowel Disease Questionnaire; RR; relative risk;
Tripartite motif-containing (TRIM) 21 negatively regulates intestinal mucosal inflammation through inhibiting TH1/TH17Â cell differentiation in patients with inflammatory bowel diseases
Keywords: Tripartite motif-containing 21; inflammatory bowel disease; CD4+ T cells; mucosal inflammation; TH1; TH17; A-CD; Active Crohn disease; A-UC; Active ulcerative colitis; CD; Crohn disease; CDAI; Crohn's Disease Activity Index; HC; Healthy control subject; I
Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's Disease
Keywords: Combined Remission; Clinical Remission; Anal Fistula; Cell Therapy; CDAI; Crohn's Disease Activity Index; CI; confidence interval; Cx601; allogeneic; expanded; adipose-derived stem cells; IBDQ; inflammatory bowel disease questionnaire; LOCF; last observ
The UltraSound-CLinical ARthritis Activity (US-CLARA) index: Properties of a new composite disease activity index for rheumatoid arthritis
Keywords: ACPA; anti-citrullinated protein antibodies; ACR; American College of Rheumatology; AUC; area under the curve; BMI; body mass index; CDAI; Clinical Disease Activity Index; CI; confidence interval; CRP; C-reactive protein; DAS28; disease activity score-28
The impact of immunogenicity of TNFα inhibitors in autoimmune inflammatory disease. A systematic review and meta-analysis
Keywords: ADA; antidrug antibodies; AEs; adverse events; ADL; Adalimumab; AS; ankylosing spondylitis; ASDAS; Ankylosing Spondylitis Disease Activity Score; BASDAI; Bath Ankylosing Spondylitis Disease Activity Index; CD; Crohn's disease; CDAI; Crohn's Disease Activi
American Gastroenterological Association Institute Technical Review on the Management of Crohn's Disease After Surgical Resection
Keywords: AGA; American Gastroenterological Association; 5-ASA; 5-aminosalicylate; CD; Crohn's disease; CDAI; Crohn's Disease Activity Index; CI; confidence interval; GRADE; Grading of Recommendations Assessment, Development and Evaluation; NMA; network meta-an
Efficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn's Disease: A Phase 2a Study
Keywords: IL23; IL22; Clinical Trial; Phase II; CD; Crohn's disease; CDAI; Crohn's Disease Activity Index; CI; confidence interval; CRP; C-reactive protein; IL; interleukin; IRB; Institutional Review Board; TNF; tumor necrosis factor;
Complementary and Alternative Medicines Used by Patients With Inflammatory Bowel Diseases
Keywords: Herbal Medicine; Acupuncture; Exercise; Probiotics; CAM; complementary and alternative medicine; CB; cannabinoid; CD; Crohn's disease; CDAI; Crohn's disease activity index; EPA; eicosapentaenoic acid; EPIC; Epanova Program in Crohn's Study; IBD; infla
Endoscopy and cross-sectional imaging for assessing Crohn׳s disease activity
Keywords: Crohn׳s disease; Disease activity; Therapeutic monitoring; MR-enterography; CT-enterography; CDEIS; SES-CD; CDAI; MaRIA;